News

Bio-Techne To Acquire Exosome Diagnostics, Inc

exosomes

Bio-Techne Corporation announced today that it has reached agreement to acquire Exosome Diagnostics, Inc. for $250 million in cash plus contingent consideration of up to $325 million due upon the achievement of certain future milestones. The transaction is expected to ...

Read More »